Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Current Fiscal Year End Date Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Common Stock Shares Outstanding Document Quarterly Report Document Transition Report Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Address Address Line 1 Entity Address City Or Town Entity Address Postal Zip Code City Area Code Local Phone Number Security 12b Title Trading Symbol Security Exchange Name Entity Interactive Data Current Entity Address Country Condensed Consolidated Balance Sheets Assets Current assets Cash and cash equivalents Sales tax, tax credits and other receivables (Note 3) Prepaid expenses and deposits (Note 4) Assets held for sale (Note 5) Total current assets [Assets, Current] Investment in joint venture (Note 10) Property, plant and equipment, net (Note 6) Intangible assets, net (Note 7) Total assets [Assets] Liabilities and Stockholders' Equity Current liabilities Accounts payable and accrued liabilities (Note 9) Current portion of long-term debt (Note 11) Total current liabilities [Liabilities, Current] Long-term debt (Note 11) Total liabilities [Liabilities] Stockholders' Equity Series A Preferred stock par value $0.0001; 25,000,000 shares authorized; one share issued and outstanding Common stock par value $0.0001: 250,000,000 shares authorized; 47,160,164 shares issued and outstanding (February 28, 2021 - 42,413,691) (Note 13) Additional paid-in capital Additional paid-in capital - Warrants (Note 18) Accumulated deficit Accumulated other comprehensive loss [Accumulated Other Comprehensive Income (Loss), Net of Tax] Total stockholders' equity [Stockholders' Equity Attributable to Parent] Total liabilities and stockholders' equity [Liabilities and Equity] Stockholders' Equity Series A preferred stock, par value Series A preferred stock, share authorized Series A preferred stock, share issued Series A preferred stock, share outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Revenue Expenses Research and development (Note 14) General and administrative (Note 15) Depreciation and amortization (Notes 6 and 7) Interest and other financial expenses (Note 19) Interest income [Interest and Dividend Income, Operating] Foreign exchange loss (gain) Total expenses [Operating Expenses] Net Loss Other comprehensive income (loss) Foreign currency translation adjustment Comprehensive income (loss) Loss per share Basic and Diluted Weighted average common shares outstanding Basic and Diluted [Weighted Average Number of Shares Outstanding, Basic and Diluted] Condensed Consolidated Statement of Changes in Stockholders Equity (Unaudited) Statement [Table] Statement [Line Items] Statement Equity Components Axis Common Stock Series A, Preferred Stock Additional Paid-In Capital Additional Paid-in Capital -Warrants [Member] Retained Earnings (Accumulated Deficit) Accumulated other comprehensive loss AOCI Attributable to Parent [Member] Balance, shares [Shares, Issued] Balance, amount Warrant issued for services (Note 18) Issuance of shares upon the vesting of restricted stock units (Note 16), shares Issuance of shares upon the vesting of restricted stock units (Note 16), amount Stock options issued for services (Note 16) Restricted stock units issued for services (Note 16) Foreign currency translation Net loss Issuance of common shares and warrants for cash, net of share issuance costs (Note 13), shares Issuance of common shares and warrants for cash, net of share issuance costs (Note 13), amount Issuance of warrants for financing facility (Notes 11 and 18) Balance, shares Balance, amount Condensed Consolidated Statements of Cash Flows (Unaudited) Cash Flows from Operating Activities Net loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization (Notes 6 and 7) Stock-based compensation expense (Note 16) Accretion and accrued interest expenses (Note 19) Loss on revaluation of foreign exchange contracts (Note 19) Changes in operating assets and liabilities: Sales tax and tax credits receivable (Note 3) Prepaid expenses (Note 4) Accounts payable and accrued liabilities (Note 9) [Increase (Decrease) in Accounts Payable and Accrued Liabilities] Net cash used in operating activities [Net Cash Provided by (Used in) Operating Activities] Cash Flows from Investing Activities Investment in joint venture (Note 10) [Payments to Acquire Interest in Joint Venture] Deposits on machinery and equipment (Note 4) Additions to property, plant and equipment (Notes 5 and 6) [Payments to Acquire Property, Plant, and Equipment] Additions to intangible assets (Note 7) [Payments to Acquire Intangible Assets] Net cash used in investing activities [Net Cash Provided by (Used in) Investing Activities] Cash Flows from Financing Activities Proceeds from sale of common shares and warrants, net of share issuance costs (Note 13) Proceeds from issuance of long-term debt (Note 11) Repayment of long-term debt (Note 11) [Repayments of Long-term Debt] Net cash (used) provided by financing activities [Net Cash Provided by (Used in) Financing Activities] Effect of exchange rate changes Net increase (decrease) in cash Cash, beginning of period Cash, end of period Supplemental Disclosure of Cash Flow Information: Income tax paid Interest paid Interest received The Company, Basis of Presentation 1. The Company, Basis of Presentation Summary of Significant Accounting Policies 2. Summary of Significant Accounting Policies Sales Tax, Tax Credits and Other Receivables 3. Sales Tax, Tax Credits and Other Receivables Prepaid Expenses and Deposits 4. Prepaid Expenses and Deposits Assets held for sale 5. Assets held for sale Property, Plant and Equipment 6. Property, Plant and Equipment Intangible Assets 7. Intangible Assets Fair Value of Financial Instruments 8. Fair Value of Financial Instruments Accounts Payable and Accrued Liabilities 9. Accounts Payable and Accrued Liabilities Joint Venture 10. Joint Venture Long-Term Debt 11. Long-Term Debt Related Party Transactions 12. Related Party Transactions 13. Stockholders' Equity Research and Development Expenses 14. Research and development expenses General and Administrative Expenses 15. General and Administrative Expenses Share-Based Payments 16. Share-Based Payments Equity Incentive Plan 17. Equity Incentive Plan Warrants 18. Warrants Interest and Other Finance Costs 19. Interest and Other Finance Costs Commitments and Contingencies 20. Commitments and Contingencies Use of estimates Stock-based compensation Research and development expenses Assets held for sale Discontinued Operations, Policy [Policy Text Block] Foreign currency translations and transactions Net earnings (loss) per share Sales tax, tax credits and other receivables Prepaid expenses Summarizes cost of assets held for sale Property, plant and equipment Fair value of financial instruments Accounts payable and accrued liabilities Long-term debt Principal repayments Common stock Summarizes the allocation of the aggregate purchase price Research and development expenses [Research and development expenses] General and Administrative expenses Equity incentive plan Summarizes the warrants of granted Interest and other financial costs Related Party Transaction [Axis] Indorama Loop Technologies, LLC [Member] Ownership, percentage Financial Instrument [Axis] Award Type Axis Stock Options [Member] Restricted Stock Units Warrants [Warrants] Research and development expenses [Research and development expenses 1] Antidilutive securities Sales tax Research and development tax credits Other receivables Sales tax, research and development tax credits and other receivables Deposits on machinery and equipment Other Prepaid expenses Non refundable deposits on machinery and equipment Assets held for sale (Details) Long Lived Assets Held-for-sale by Asset Type [Axis] Property, plant and equipment, net [Member] Assets held for sale [Member] Total Assets held for sale Assets Held-for-sale, Description Land acquired descriprtion Land acquired for cash, amount Property Plant And Equipment By Type Axis Product and Service [Axis] Building [Member] Land [Member] Building and Land Improvements [Member] Machinery and Equipment [Member] Office Equipment and Furniture [Member] Property, plant and equipment, gross Less: accumulated depreciation, write-down and impairment [Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment] Property, plant and equipment, net Depreciation expense Intangible assets Additions to intangible assets Amortization expense Fair Value By Fair Value Hierarchy Level Axis Long-term Debt [Member] Level 2 [Member] Total liabilities Fair value Trade accounts payable Accrued engineering fees Accrued employee compensation Accrued professional fees Other accrued liabilities Accounts payable and accrued liabilities [Accounts Payable and Accrued Liabilities] Investment in joint venture Equity method investment, carrying value Debt Instrument Axis Investissement Qu?bec Financing Facility [Member] Term Loan [Member] Long-term debt, net of current portion Principal amount Unamortized discount [Debt Instrument, Unamortized Discount] Accrued interest Less: current portion February 28, 2022 February 28, 2023 February 29, 2024 February 28, 2025 February 28, 2026 Thereafter Total First Disbursement Warrant [Member] Second Disbursement Warrant [Member] Ramaining financing facility Interest expense Mximum financing facility Disbursement from financing facility Interest rate on loan Number of monthly installments Fair value of the loan for the disbursement Discount rate Loan fees Debt discount Accretion expense Warrant exercise price Warrants issued to purchase common stock, amount Warrant term Warrants issued to purchase common stock, shares Fair value of warrant Repayment of long-term debt Loan amount Loan, term Loan, interest rate description Monthly repayment of loan Interest paid [Interest Paid, Including Capitalized Interest, Operating and Investing Activities] Related Party [Axis] President and Chief Executive Officer Restricted Stock Units Shares granted Closing price per share Business Acquisition [Axis] Common Stock [Member] Issuance of shares upon settlement of restricted stock units, shares Issuance of shares upon settlement of restricted stock units, amount Issuance of shares for cash, shares Issuance of shares for cash, amount Class of Warrant or Right [Axis] First Tranche Warrants [Member] Second Tranche Warrants [Member] Third Tranche Warrants [Member] Aggregate purchase price, net of issuance costs SKGC Investment [Member] First Tranche Warrants [Member] Second Tranche Warrants [Member] Third Tranche Warrants [Member] Offering price per share Issuance of shares upon the vesting of restricted stock units Issuance of shares for cash, shares Gross proceeds from issuance of shares with warrants Net proceeds from issuance of shares with warrant Aggregate purchase price Shares of common stock sold Issued and outstanding common stock, contribution Warrant exercise price [Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price] Research And Development Arrangement Contract To Perform For Others By Type Axis Machinery and Equipment [Member] Employee Compensation [Member] External Engineering [Member] Plant and Laboratory Operating Expenses [Member] Other [Member] Research and development expenses [Research and Development Expense] Research and development, tax credits Research and development, government grants Nature Of Expense Axis Professional fees [Member] Employee Compensation [Member] Directors and officers insurance [Member] Other [Member] [Other [Member]] General and administrative expenses Net reversal of stock-based compensation Income Statement Location Axis Research and Development Expenses Research and Development Expense [Member] General and Administrative Expenses General and Administrative Expense [Member] Stock options granted Stock options forfeited Stock options expired Issuances of stock options Stock options outstanding Stock options outstanding, weighted average exercise price Stock options exercisable Stock options exercisable, weighted average exercise price Stock-based compensation expense Restricted stock units granted Restricted stock units granted, weighted average exercise price Restricted stock units settled Restricted stock units settled, weighted average exercise price Restricted stock units forfeited Restricted stock units forfeited, weighted average exercise price Restricted stock units outstanding Restricted stock units vested Restricted stock unit expense Net reversal in expenses attributable to RSUs Net reversal in stock-based compensation Equity Incentive Plan [Equity Incentive Plan] Outstanding, beginning of period Share reserve increase Units granted Units forfeited Units expired Outstanding, end of period Plan Name [Axis] 2017 Equity Incentive Plan Common stock shares reserved for future issuance Common stock shares reserved for future issuance annual increase Expected life Voting power percentage Life of option Common stock outstanding shares percentage Warrants 1 Warrants 2 Warrants 3 Warrants 4 Number of warrants Exercise Price Expiration date Warrants to issue shares of common stock Warrants to issue shares of common stock exercise price Warrant to purchase common stock shares for for consulting services Warrant to purchase common stock shares for for consulting services, per share price Warrants issued Interest on long-term debt Accretion expense [Accretion Expense] Loss (gain) on revaluation of foreign exchange contracts Other Interest and finance costs Interest and other finance costs Cumulative amount paid Total amount of Chemtex Agreement Milestones payments facility Net reversal in expenses attributable to RSUs Net reversal in stock-based compensation. Milestones payments facility. The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group. The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a